Byers Capital

PinkDx is a biotechnology company specializing in women's health. It develops molecular tests to improve diagnostic outcomes for women with vague gynecological cancer symptoms, offering alternatives to invasive procedures. This enables more comfortable and efficient resolution of health concerns, providing timely and positive impacts on patients' lives.

Waltz Health is focused on enhancing the pharmaceutical supply chain by collaborating with consumers, payers, and pharmacies to develop innovative, technology-driven solutions for pricing, distribution, and prescription of medications. The company creates AI-driven marketplaces that aim to reduce costs and provide valuable insights for users, facilitating informed decision-making in prescription care. By offering consumer tools designed to empower individuals and help payers manage their pharmacy benefits, Waltz Health strives to improve accessibility and affordability in the healthcare sector.

Ostro is a health platform that specializes in personalized engagement solutions for the life sciences sector. Established in 2019 and headquartered in Miami, Florida, Ostro connects the creators of medicines with their users, enhancing healthcare journeys for both consumers and healthcare professionals. The platform facilitates a streamlined patient experience by integrating virtual consultations, logistics, regulatory compliance, and payment services. Through its innovative approach, Ostro aims to improve health outcomes by fostering informed connections and driving engagement, ultimately benefiting patients and life sciences brands alike.

Getlabs, Inc. is a digital health platform based in Santa Monica, California, that specializes in at-home diagnostics. Founded in 2018, the company facilitates the scheduling of home lab appointments, where mobile phlebotomists visit patients to collect blood samples and other diagnostic tests. These samples are then delivered to laboratories for processing, allowing healthcare organizations to enhance patient care and adherence by providing same-day, nationwide service. Getlabs aims to bridge the gap between virtual and in-person healthcare, thereby improving access to essential diagnostic services. The company has secured $50 million in funding from strategic investors, including major diagnostic laboratories.

Culdesac Inc. is a real estate developer based in San Francisco, California, focused on creating car-free neighborhoods in the United States. Founded in 2018, the company is currently developing its first project in Tempe, Arizona, which aims to be the first car-free residential community built from scratch in the country. This innovative neighborhood will feature no parking spaces for residents, instead providing facilities for visitors, including grocery stores, coffee shops, coworking spaces, and market halls. By promoting eco-friendly living, Culdesac encourages residents to engage with their surroundings directly, enhancing their quality of life and fostering community interaction. The company has secured $17 million in venture funding from notable investors, including Khosla Ventures, Zigg Capital, and Initialized Capital.

Benchling, Inc. is a cloud-based informatics company that provides a comprehensive platform tailored for life sciences research and development. Its flagship offering allows scientists to design, share, and document experiments through an integrated interface, enhancing collaboration and efficiency. The platform includes Benchling Insights, which enables users to query and visualize structured data, and a Bioregistry system for managing biological entity registrations and inventory such as plasmids and cell strains. Benchling's solutions support a variety of applications, including antibodies, cell therapy, gene therapy, and vaccines, catering to the needs of scientists in biotech, pharmaceutical, academic, and government sectors. Founded in 2012 and headquartered in San Francisco, Benchling aims to streamline the research process from discovery to bioprocessing, facilitating critical R&D decisions with its unified software suite.

Ostro is a health platform that specializes in personalized engagement solutions for the life sciences sector. Established in 2019 and headquartered in Miami, Florida, Ostro connects the creators of medicines with their users, enhancing healthcare journeys for both consumers and healthcare professionals. The platform facilitates a streamlined patient experience by integrating virtual consultations, logistics, regulatory compliance, and payment services. Through its innovative approach, Ostro aims to improve health outcomes by fostering informed connections and driving engagement, ultimately benefiting patients and life sciences brands alike.